Autoimmune epilepsy

Michel Toledano, Sean J Pittock

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Seizures are recognized as a common manifestation of autoimmune limbic encephalitis and multifocal paraneoplastic disorders, but accumulating evidence supports an autoimmune basis for seizures in the absence of syndromic manifestations of encephalitis. Autoimmune encephalitis and epilepsy have been linked to neural-specific autoantibodies targeting both intracellular and plasma membrane antigens. The detection of these antibodies can serve as a diagnostic marker directing physicians toward specific cancers and can assist in therapeutic decision-making, but are not necessary to establish the diagnosis. Response to an immunotherapy trial can support the diagnosis and help establish prognosis. Early recognition is important because expedited diagnosis can facilitate recovery. In this review, the authors summarize the clinical presentation, pathophysiology, and management of autoimmune epilepsies for which neural antigen-specific autoantibodies serve as diagnostic aids.

Original languageEnglish (US)
Pages (from-to)245-258
Number of pages14
JournalSeminars in Neurology
Volume35
Issue number3
DOIs
StatePublished - Jun 12 2015

Fingerprint

Epilepsy
Autoantibodies
Antigens
Absence Epilepsy
Intracellular Membranes
Encephalitis
Immunotherapy
Decision Making
Seizures
Cell Membrane
Physicians
Antibodies
Neoplasms
Therapeutics
Recognition (Psychology)
Hashimoto's encephalitis
Autoimmune limbic encephalitis

Keywords

  • antibodies
  • autoimmune
  • epilepsy
  • inflammation

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Autoimmune epilepsy. / Toledano, Michel; Pittock, Sean J.

In: Seminars in Neurology, Vol. 35, No. 3, 12.06.2015, p. 245-258.

Research output: Contribution to journalArticle

Toledano, Michel ; Pittock, Sean J. / Autoimmune epilepsy. In: Seminars in Neurology. 2015 ; Vol. 35, No. 3. pp. 245-258.
@article{fc8b6a14ef104a0eb87a33942fbfd5f0,
title = "Autoimmune epilepsy",
abstract = "Seizures are recognized as a common manifestation of autoimmune limbic encephalitis and multifocal paraneoplastic disorders, but accumulating evidence supports an autoimmune basis for seizures in the absence of syndromic manifestations of encephalitis. Autoimmune encephalitis and epilepsy have been linked to neural-specific autoantibodies targeting both intracellular and plasma membrane antigens. The detection of these antibodies can serve as a diagnostic marker directing physicians toward specific cancers and can assist in therapeutic decision-making, but are not necessary to establish the diagnosis. Response to an immunotherapy trial can support the diagnosis and help establish prognosis. Early recognition is important because expedited diagnosis can facilitate recovery. In this review, the authors summarize the clinical presentation, pathophysiology, and management of autoimmune epilepsies for which neural antigen-specific autoantibodies serve as diagnostic aids.",
keywords = "antibodies, autoimmune, epilepsy, inflammation",
author = "Michel Toledano and Pittock, {Sean J}",
year = "2015",
month = "6",
day = "12",
doi = "10.1055/s-0035-1552625",
language = "English (US)",
volume = "35",
pages = "245--258",
journal = "Seminars in Neurology",
issn = "0271-8235",
publisher = "Thieme Medical Publishers",
number = "3",

}

TY - JOUR

T1 - Autoimmune epilepsy

AU - Toledano, Michel

AU - Pittock, Sean J

PY - 2015/6/12

Y1 - 2015/6/12

N2 - Seizures are recognized as a common manifestation of autoimmune limbic encephalitis and multifocal paraneoplastic disorders, but accumulating evidence supports an autoimmune basis for seizures in the absence of syndromic manifestations of encephalitis. Autoimmune encephalitis and epilepsy have been linked to neural-specific autoantibodies targeting both intracellular and plasma membrane antigens. The detection of these antibodies can serve as a diagnostic marker directing physicians toward specific cancers and can assist in therapeutic decision-making, but are not necessary to establish the diagnosis. Response to an immunotherapy trial can support the diagnosis and help establish prognosis. Early recognition is important because expedited diagnosis can facilitate recovery. In this review, the authors summarize the clinical presentation, pathophysiology, and management of autoimmune epilepsies for which neural antigen-specific autoantibodies serve as diagnostic aids.

AB - Seizures are recognized as a common manifestation of autoimmune limbic encephalitis and multifocal paraneoplastic disorders, but accumulating evidence supports an autoimmune basis for seizures in the absence of syndromic manifestations of encephalitis. Autoimmune encephalitis and epilepsy have been linked to neural-specific autoantibodies targeting both intracellular and plasma membrane antigens. The detection of these antibodies can serve as a diagnostic marker directing physicians toward specific cancers and can assist in therapeutic decision-making, but are not necessary to establish the diagnosis. Response to an immunotherapy trial can support the diagnosis and help establish prognosis. Early recognition is important because expedited diagnosis can facilitate recovery. In this review, the authors summarize the clinical presentation, pathophysiology, and management of autoimmune epilepsies for which neural antigen-specific autoantibodies serve as diagnostic aids.

KW - antibodies

KW - autoimmune

KW - epilepsy

KW - inflammation

UR - http://www.scopus.com/inward/record.url?scp=84930938202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930938202&partnerID=8YFLogxK

U2 - 10.1055/s-0035-1552625

DO - 10.1055/s-0035-1552625

M3 - Article

C2 - 26060904

AN - SCOPUS:84930938202

VL - 35

SP - 245

EP - 258

JO - Seminars in Neurology

JF - Seminars in Neurology

SN - 0271-8235

IS - 3

ER -